NCT02793466 2023-09-22Durvalumab in Pediatric and Adolescent PatientsChildren's Hospital Los AngelesPhase 1 Completed15 enrolled
NCT03054532 2017-02-16Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell LymphomaSingapore General HospitalPhase 2 Unknown22 enrolled